A $12.6 million federal award will establish a UC San Diego research center focused on why addiction develops across more than one substance and why relapse occurs. The five-year Polysubstance Addiction Research Center will combine work in psychiatry, medicine, reproductive sciences, computational biology and bioinformatics with the Veterans Affairs San Diego Healthcare System.
The premise is that the traditional separation of alcohol, stimulant and opioid research does not match how many people use drugs. The center will study cocaine, oxycodone, alcohol and a cocaine-oxycodone combination through a coordinated design. Comparing those exposures can reveal mechanisms they share while preserving differences that may matter for prevention or treatment.
The National Institute on Drug Abuse is funding the project. Olivier George, a UC San Diego psychiatry professor, will direct it. The announcement describes a research program, not a clinical service or a new treatment. Its immediate products will be data, methods and tested biological hypotheses; any application to patient care would require additional validation beyond the initial studies.
Three projects divide the work. One will map how addiction changes communication among brain networks. A second will measure shifts in gene activity within specific brain-cell types. A third will examine the gut, metabolism and the vagus nerve, the major pathway connecting the brain with internal organs. The projects are designed to study the same problem at several biological scales.
Researchers call the combined framework a One-Individual Multiscale Atlas. Behavioral measures will be aligned with information from genes, cells, brain circuits, immune activity and organs. Computational and machine-learning tools will then look for patterns associated with vulnerability or severity. A pattern found by an algorithm is still an association; it does not by itself establish that one biological change caused addictive behavior.
The center's second aim addresses that distinction. After identifying candidate markers, researchers plan experiments that test whether changing a biological target alters addiction-related behavior. That move from correlation toward intervention is essential. It can rule out signals that merely travel with addiction and concentrate later work on mechanisms that have a functional role.
Human genetic, brain-imaging and other biological datasets will provide another comparison layer. They may show whether findings from controlled models appear in people, but differences in environment, history and patterns of use remain important. Studying four substance conditions also will not represent every combination used outside a laboratory. The design is broader than a single-drug study, not a complete map of polysubstance use.
Variation among individuals is another core question. The program will ask why the same exposure produces more severe addiction-related behavior in some subjects than others. Genetic differences are one candidate, but the atlas also includes immune, metabolic and neural measures. Integrating them may identify subgroups that would be hidden if every participant were averaged into one response.
The center's value will be judged by whether its layers of data converge. A molecular signal that also appears in a brain circuit, behavior and human dataset is more informative than an isolated result, especially if an experiment can alter it. The award gives UC San Diego five years to build that chain of evidence. It does not guarantee a therapy, but it creates a structure for asking a question that fragmented research has often missed.